| Multi-step pericellular proteolysis controls the transition from individual to collective cancer cell invasion K Wolf, YI Wu, Y Liu, J Geiger, E Tam, C Overall, MS Stack, P Friedl Nature cell biology 9 (8), 893-904, 2007 | 1216 | 2007 |
| Angiostatin binds ATP synthase on the surface of human endothelial cells TL Moser, MS Stack, I Asplin, JJ Enghild, P Højrup, L Everitt, S Hubchak, ... Proceedings of the National Academy of Sciences 96 (6), 2811-2816, 1999 | 742 | 1999 |
| The mechanism of cancer-mediated conversion of plasminogen to the angiogenesis inhibitor angiostatin S Gately, P Twardowski, MS Stack, DL Cundiff, D Grella, FJ Castellino, ... Proceedings of the National Academy of Sciences 94 (20), 10868-10872, 1997 | 399 | 1997 |
| Processing of laminin-5 and its functional consequences: role of plasmin and tissue-type plasminogen activator LE Goldfinger, MS Stack, JCR Jones The Journal of cell biology 141 (1), 255-265, 1998 | 398 | 1998 |
| Membrane protease proteomics: Isotope-coded affinity tag MS identification of undescribed MT1–matrix metalloproteinase substrates EM Tam, CJ Morrison, YI Wu, MS Stack, CM Overall Proceedings of the National Academy of Sciences 101 (18), 6917-6922, 2004 | 338 | 2004 |
| Lysophosphatidic acid promotes matrix metalloproteinase (MMP) activation and MMP-dependent invasion in ovarian cancer cells DA Fishman, Y Liu, SM Ellerbroek, MS Stack Cancer research 61 (7), 3194-3199, 2001 | 335 | 2001 |
| Proteases, extracellular matrix, and cancer: a workshop of the path B study section YA DeClerck, AM Mercurio, MS Stack, HA Chapman, MM Zutter, ... The American journal of pathology 164 (4), 1131-1139, 2004 | 320 | 2004 |
| Proinvasive properties of ovarian cancer ascites-derived membrane vesicles LE Graves, EV Ariztia, JR Navari, HJ Matzel, MS Stack, DA Fishman Cancer research 64 (19), 7045-7049, 2004 | 313 | 2004 |
| Engagement of collagen-binding integrins promotes matrix metalloproteinase-9–dependent E-cadherin ectodomain shedding in ovarian carcinoma cells J Symowicz, BP Adley, KJ Gleason, JJ Johnson, S Ghosh, DA Fishman, ... Cancer research 67 (5), 2030-2039, 2007 | 310 | 2007 |
| Human prostate carcinoma cells express enzymatic activity that converts human plasminogen to the angiogenesis inhibitor, angiostatin S Gately, P Twardowski, MS Stack, M Patrick, L Boggio, DL Cundiff, ... Cancer Research 56 (21), 4887-4890, 1996 | 289 | 1996 |
| Human mast cell tryptase activates single-chain urinary-type plasminogen activator (pro-urokinase) MS Stack, DA Johnson Journal of Biological Chemistry 269 (13), 9416-9419, 1994 | 273 | 1994 |
| Phosphatidylinositol 3-kinase activity in epidermal growth factor-stimulated matrix metalloproteinase-9 production and cell surface association SM Ellerbroek, JM Halbleib, M Benavidez, JK Warmka, EV Wattenberg, ... Cancer research 61 (5), 1855-1861, 2001 | 257 | 2001 |
| Wnt5a signaling in cancer MS Asem, S Buechler, RB Wates, DL Miller, MS Stack Cancers 8 (9), 79, 2016 | 249 | 2016 |
| Epithelial ovarian cancer experimental models E Lengyel, JE Burdette, HA Kenny, D Matei, J Pilrose, P Haluska, ... Oncogene 33 (28), 3619-3633, 2014 | 234 | 2014 |
| Phenotypic plasticity of neoplastic ovarian epithelium: unique cadherin profiles in tumor progression LG Hudson, R Zeineldin, MS Stack Clinical & experimental metastasis 25, 643-655, 2008 | 234 | 2008 |
| Inhibition of purified collagenase from alkali-burned rabbit corneas. FR Burns, MS Stack, RD Gray, CA Paterson Investigative ophthalmology & visual science 30 (7), 1569-1575, 1989 | 229 | 1989 |
| Matrix metalloproteinase 9 is a mediator of epidermal growth factor–dependent E-cadherin loss in ovarian carcinoma cells KD Cowden Dahl, J Symowicz, Y Ning, E Gutierrez, DA Fishman, ... Cancer research 68 (12), 4606-4613, 2008 | 226 | 2008 |
| Functional interplay between type I collagen and cell surface matrix metalloproteinase activity SM Ellerbroek, YI Wu, CM Overall, MS Stack Journal of Biological Chemistry 276 (27), 24833-24842, 2001 | 221 | 2001 |
| Ovarian carcinoma regulation of matrix metalloproteinase-2 and membrane type 1 matrix metalloproteinase through β1 integrin SM Ellerbroek, DA Fishman, AS Kearns, LM Bafetti, MS Stack Cancer research 59 (7), 1635-1641, 1999 | 208 | 1999 |
| In vivo tumor growth of high-grade serous ovarian cancer cell lines AK Mitra, DA Davis, S Tomar, L Roy, H Gurler, J Xie, DD Lantvit, ... Gynecologic oncology 138 (2), 372-377, 2015 | 196 | 2015 |
